Sarah P. Psutka MD, MS

Sarah Psutka, MD, MSc, is a urologic oncologist and Associate Professor of Urology at the University of Washington. She received her AB in Biology from Harvard College in 2003 and her MD from Harvard Medical School in 2007. She then completed an internship in General Surgery and Residency in Urology at the Massachusetts General Hospital in 2013. During this time, she completed the Clinical Effectiveness Research Diploma at the Harvard School of Public Health. She subsequently completed a Society of Urologic Oncology Fellowship in Urologic Oncology at the Mayo Clinic, and concurrently obtained her Masters in Clinical and Translational Science from the Mayo School of Graduate Medical Education in 2015.

Following completion of her training, she joined the staff of the John H. Stroger Jr. Hospital of Cook County in Chicago where she served as the Director of Urologic Oncology. During this time, Dr. Psutka was named Assistant Professor of Urology at the Northwestern Feinberg School of Medicine. In 2018, she was recruited to join the faculty of the University of Washington, where she now practices as a Urologic Oncologist and is the Associate Program Director of the Urologic Oncology Fellowship. Her clinical practice focuses on the treatment of bladder cancer, renal cell carcinoma, and testis cancer. From a research standpoint, her main area of interest is in the study and development of personalized, comprehensive risk stratification measures in patients with urologic malignancies, particularly bladder cancer.

She is focused on developing and validating risk stratification programs that will help patients better choose the optimal therapy for them, with the goal of not only improving personalized oncologic outcomes, but also patient reported outcomes such as quality of life. Specifically, she has expertise in the study of precise measurements of frailty and body composition with a focus on sarcopenia. She currently sits on the Editorial Board of European Urology as an associated editor. She is committed to advancing opportunities for women and underrepresented minorities in urology, urologic oncology, and academic medicine and co-founded the Society for Women in Urologic Oncology in 2018.